Fight over $1,100 hepatitis C pills awaits next move by CVS>
Giliead could have no choice but to negotiate its own discounts with CVS Health and other drug benefit managers, say analysts, after rival drugmaker AbbVie decided to block Gilead's pill Harvoni from a...
View ArticleWorkers take a stand as evidence mounts against sitting>
The software engineer in Austin, Texas, used parts from Ikea for a makeshift desk to prop up his keyboard and monitor, letting him avoid the excessive sitting he had heard was bad for him. Employers...
View Article10 Ways to Improve Sleep for Wellness and Weight Loss
Did you know that a good night's sleep is the secret ingredient to slimming down your waistline and boosting overall health? Lack of sleep causes hormone imbalances, specifically the hormones that...
View ArticleLawyers use online data to find plaintiffs in medical suits
Using information culled from digital sources, law firms solicit clients who want to claim damages. /a...
View Article6 Tips for a Summertime Sugar Detox
There is a lot of buzz about sugar lately and how it can impact wellness, but why exactly is sugar problematic and how can you reduce sugar to boost health? I am pleased to help decode how sugar...
View ArticleCelgene pays $1 billion for stake in Juno cancer research
Celgene Corp. will pay Juno Therapeutics Inc. about $1 billion as part of a 10-year partnership to study cures for cancer and autoimmune diseases, the largest payment in a...
View ArticleHorizon Pharma makes hostile $3B bid for Newark's Depomed
Horizon Pharma, a biopharmaceutical company developing treatments for rare diseases, made an unsolicited bid to buy Newark-based Depomed for $3 billion, including debt, after earlier attempts to make a...
View ArticleNovavax's Ebola vaccine shows human immune response
Novavax Inc.'s Ebola vaccine helped healthy people develop an immune response against the deadly virus in an early trial....
View ArticlePat Green performs intimate benefit concert in Galveston
Texas singer/songwriter Pat Green performed a sold-out benefit concert for the Gulf Coast Big Brothers and Big Sisters organization in Galveston's 1894 Grand Opera House Saturday.......
View ArticleGilead’s hepatitis C drug works against all strains in trial
An experimental hepatitis C drug combination from Gilead Sciences Inc. wiped out all strains of the virus in a large clinical trial, giving the...
View ArticleMerck’s shorter-term hep C drugs work in trial
Merck & Co.’s experimental hepatitis C drug combinations were effective against two common strains of the disease in a midstage trial...
View ArticleFall Stress Busters -- A Seasonal Guide to Managing Stress, Naturally
As autumn sets in and temperatures drop, many of us are facing challenges, including work and school schedules, and soon holiday-related tasks. In reaction, we often experience "stress triggers" (like...
View ArticleMerck hepatitis C drug shows promise for users
BOSTON — Hepatitis C patients who use intravenous drugs were cured at a high rate by Merck & Co.’s experimental therapy, a study found, a result that could put pressure on U.S. states to more...
View ArticleHep C in addicts cured by Merck drug at high rate in trial
Hepatitis C patients who use intravenous drugs were cured at a high rate by Merck & Co.’s experimental therapy, a study found, a result that could put pressure on states to more broadly cover...
View ArticleEx-Biogen head of R&D thinks small with Codiak
After four years at the biotech giant, he’s moving to a far smaller company to investigate a technology based on tiny containers discharged by cells. The company is...
View ArticleMylan receives subpoena as U.S. generic drug price probe widens
Generic drug maker Mylan NV received a subpoena from the U.S. Department of Justice seeking information on the marketing and pricing of one of its antibiotics, bringing the company into a widening...
View ArticleJustice Dept. subpoenas Mylan
Generic drug maker Mylan NV received a subpoena from the U.S. Department of Justice seeking information on the marketing and pricing of one of its antibiotics, bringing the company into a widening...
View ArticleAlexion wins approval for drug to treat rare disease
Alexion Pharmaceuticals Inc.’s drug for a rare and deadly genetic disease won approval from regulators, giving the biotechnology company its first treatment from its...
View Article‘Wolf of Pharma Street’ holds up unwelcome mirror to industry
Martin Shkreli, arrested Thursday, widely reviled for jacking up prices of established medications Despite notoriety, pricing practices no different from others in pharmaceutical industry, experts say...
View ArticleShkreli fired as CEO of KaloBios after arrest
Martin Shkreli was fired as chief executive officer of KaloBios Pharmaceuticals Inc. following his arrest last week on charges of securities fraud. ......
View ArticleAlder shares surge on test results for migraine treatment
The Bothell-based biotech’s stock rose as much as 62 percent, its biggest intraday gain ever, after saying that its experimental infusion to prevent migraines met the main goals of a mid-stage trial....
View ArticleBiogen plunges as multiple sclerosis drug fails in trial
Biogen Inc. plunged in early trading Tuesday after an experimental drug for multiple sclerosis, investors and patients had hoped might alter the course of the neurological disease, failed in a...
View ArticlePharma group punches back on drug prices as pressure rises
A top pharmaceutical lobbying group will begin a counteroffensive against scrutiny of industry pricing practices, responding to criticism from both major U.S. political parties in a contentious...
View ArticleJuno plunges after 3 patients die in trial of cancer therapy
Juno Therapeutics Inc. plunged by a record 27 percent after three patients died in a trial for its lead cancer therapy and U.S. regulators put the study on hold, raising questions about the risks and...
View ArticleUnited Airlines suspends pilot-lawmaker who called for hanging Hillary Clinton
United Airlines suspended pilot and Republican West Virginia lawmaker Michael Folk from flying after he said Democratic presidential candidate Hillary Clinton should be hanged. “This pilot has been...
View ArticleBiogen stock jumps on report of interest from Merck, Allergan
Biogen Inc. shares spiked Tuesday after a report by the Wall Street Journal that Merck & Co. and Allergan PLC have each considered a takeover of the biotechnology company. “With the departure...
View ArticleSF biotech firm Tobira bought by Allergan
Allergan’s agreement to buy San Francisco’s Tobira Therapeutics for as much as $1.7 billion sent biotech stocks soaring Tuesday, as investors bet that buyers will emerge for...
View ArticleDeaths in cancer trials remain mystery for promising therapy
An experimental cancer therapy has shown dramatic results, including long-term cures, for patients with severe disease yet has also left puzzling questions about deaths that have occurred during some...
View ArticleNo fake sales of Soliris, Alexion says
Alexion Pharmaceuticals, the Connecticut-based company that has a manufacturing facility in Smithfield, Rhode Island, said that an internal investigation found no need to restate its past financial...
View ArticleTakeda expands cancer business in $4.66bn deal
Takeda Pharmaceutical will expand its footprint in the US oncology market with the $4.66 billion purchase of Ariad Pharmaceuticals. ......
View ArticleHands-On the Lenovo P2 | TWiT Bits
Matteo Doni of coolsmartphone.com shows off the Lenovo P2 smartphone. For the full episode, visit twit.tv/aaa/303. Hosts: Jason Howell, Florence Ion, and Ron Richards Guest: Matteo Doni Bandwidth for...
View ArticleAAA 303: Animal Style G6
This week, we'll be discussing what's next for NextBit, Hugo Barra's gettin' into VR-ahh (thanks, Burke), the Oukitel U20 Plus, Lenovo P2, Meizu M5Note and Wileyfox Swift 2 ALL in studio, and more....
View ArticleDoni-brook: Moving Hoffman to new line a deft move by Senators
Moving Hoffman to new line a deft move ......
View ArticleThe New Screen Savers 90: Live Music in Your Home with Groupmuse
Leo Laporte and Megan Morrone talk to the founder of Groupmuse, Sam Bodkin, a social network connecting musicians and audiences. We get a private classical...
View ArticleTrump visa crackdown threatens medical miracle search
From tiny startups to global giants, the companies that sustain the $324 billion U.S. biotech industry are increasingly alarmed as President Donald Trump considers following his controversial travel...
View ArticleAlexion to let go 7 percent of workforce
Alexion Pharmaceuticals, the Connecticut-based company that runs a plant in Smithfield, is laying off about 7 percent of its global workforce, according to an internal email obtained by Bloomberg, as...
View ArticleValeant shares tumble on struggle to sell assets, raise cash
Pharmaceutical company hits lowest intraday level since 2009 ......
View ArticleBiogen shares jump as earnings, Spinraza sales beat forecasts
The company’s mainstay drugs are treatments for multiple sclerosis, a group under increased threat since Roche Holding entered the market last month with Ocrevus. Though Biogen is entitled to a...
View ArticleAndy Rubin's Essential Phone | TWiT Bits
Jason Howell, Ron Richards, Florence Ion and Matteo Doni from coolsmartphone.com discuss Andy Rubin's announcement of the Essential Phone. For the full episode, visit twit.tv/aaa/320 Hosts: Jason...
View ArticleAAA 320: Smartphone Centipede
This week, we'll be discussing Andy Rubin's Essential Phone, LeEco's change of direction in the US, Android Pay's expansion, Samsung DeX, Xiaomi Mi Max 2,...
View ArticleDrug-makers losing billions in sales
Boston - Drug- makers plunged off a patent cliff earlier this decade, losing billions in sales as lucrative branded drugs lost exclusivity. An expensive lobbying effort aimed at preventing a repeat is...
View ArticleAAA 333: No Crow Oreo
We'll discuss the Essential screw-up that spilled customer data and get hands-on with the phone. Third party Google Assistant speakers are coming this fall. We get a look at several of...
View ArticleLG V30 Impressions | TWiT Bits
Florence Ion and Matteo Doni talk about their time spent with the new LG V30 premium smartphone, announced at the IFA 2017 conference in Berlin. Watch the full episode at http://twit.tv/aaa/333 Hosts:...
View ArticleXiaomi Mi6 Hands-on | TWiT Bits
Matteo Doni shows off the Xiaomi Mi6 smartphone, with an impressively premium design and top of the line specs for a modest price. For the full episode, visit twit.tv/aaa/338 Hosts: Jason Howell,...
View ArticleAAA 338: The Courage Port
This week, we'll be discussing Google's event where it announced the Pixel 2, Pixel 2 XL, Pixel Buds, PixelBook, Google Home Mini and Max, and...
View ArticleDONI-BROOK: How much is left in Craig Anderson's tank?
How much is left in Craig Anderson's tank? ......
View ArticleHonor 7X Review | TWiT Bits
Matteo Doni spent two weeks with a pre-production model of the newly announced Honor 7X smartphone and shares his thoughts on the device. For the full episode, visit twit.tv/aaa/346 Hosts: Jason...
View ArticleAAA 346: 8.1 Curious
This week, we'll be discussing Android 8.1, Android Go, the Honor 7X and Honor View 10, Doogee Mix 2, ZTE Axon M, Nuu X5, banning most...
View ArticleHuawei Honor View 10 Review | TWiT Bits
Matteo Doni reviews the Huawei Honor View 10, a reasonably priced device with an impressive dual-camera setup that integrates AI to change camera settings to match the scene. For the full episode,...
View ArticleAAA 353: Life is Like a Box of Crushed Oreos
This week, we discuss the hopeful life of Android Pi, Google Fi Bill Protection, Huawei Honor View 10 review, Samson Go Mic for smartphones,...
View Article
